ASTH as reported
Astrana Health, Inc. reported $3.53B of revenue over the trailing twelve months, +57% on the year before. 11 reported series are charted on this page, each one as filed.
$3.53B
Revenue, trailing twelve months · to Q1 2026 · +57% against the twelve months before
- Net Income
- $30M
Net Income · −14% year on year · trailing twelve months to Q1 2026
- Free Cash Flow
- $155M
Free Cash Flow · +197% year on year · trailing twelve months to Q1 2026
- Op Margin
- 2.5%
Op Margin · trailing twelve months to Q1 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $3.53B | +57% | Q1 2026 |
| Net Income | $30M | −14% | Q1 2026 |
| EPS | $0.62 | −15% | Q1 2026 |
| Gross Margin | 11% | n/a | Q1 2026 |
| Op Margin | 2.5% | n/a | Q1 2026 |
| Net Margin | 0.90% | n/a | Q1 2026 |
| ROE | 2.8% | n/a | Q1 2026 |
| ROA | 1.1% | n/a | Q1 2026 |
| ROIC | 4.9% | n/a | Q1 2026 |
| Free Cash Flow | $155M | +197% | Q1 2026 |
| P/E | 62.3 | n/a | today |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Astrana Health, Inc. (ASTH) - Revenue & ProfitRevenue & ProfitAstrana Health, Inc. (ASTH)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com